Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Decaens

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Therapeutic Advances in Chronic Disease|July 31, 2020
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibitionEloïne Bestion, Zuzana Macek Jilkova, Jean-Louis Mège, et al.
Hepato-Gastroenterology|June 8, 2013
Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteriaJean Gugenheim, Luis César Bredt, Antonio Iannelli, et al.
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2017
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic modelsCharlotte E Costentin, Giuliana Amaddeo, Thomas Decaens, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)Jean Frédéric Blanc, Audrey Debaillon-Vesque, Gaël Roth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 9, 2023
Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general populationAnne-Sophie Renard, Anita Paisant, Victoire Cartier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2011
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinomaThomas Decaens, Françoise Roudot-Thoraval, Hanaa Badran, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
Hepatology (Baltimore, Md.)|March 7, 2022
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translationRomain Barnault, Claire Verzeroli, Carole Fournier, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Therapeutic Advances in Chronic Disease|July 31, 2020
GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibitionEloïne Bestion, Zuzana Macek Jilkova, Jean-Louis Mège, et al.
Hepato-Gastroenterology|June 8, 2013
Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteriaJean Gugenheim, Luis César Bredt, Antonio Iannelli, et al.
Clinics and Research in Hepatology and Gastroenterology|April 11, 2022
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic responseJessica Azzi, Céline Dorival, Carole Cagnot, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 16, 2017
Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic modelsCharlotte E Costentin, Giuliana Amaddeo, Thomas Decaens, et al.
Gastroenterology|April 10, 2013
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resectionJean-Charles Nault, Aurélien De Reyniès, Augusto Villanueva, et al.
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)Jean Frédéric Blanc, Audrey Debaillon-Vesque, Gaël Roth, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 9, 2023
Validation of a screening algorithm for hepatic fibrosis by Doppler ultrasound and elastography in a general populationAnne-Sophie Renard, Anita Paisant, Victoire Cartier, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2011
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinomaThomas Decaens, Françoise Roudot-Thoraval, Hanaa Badran, et al.
Autophagy|November 6, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma <i>via</i> modulation of lysosomal functionsSonia Brun, Eloïne Bestion, Eric Raymond, et al.
Hepatology (Baltimore, Md.)|March 7, 2022
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translationRomain Barnault, Claire Verzeroli, Carole Fournier, et al.
Pageof 13